Technical Articles
Human KRAS G12C & cRAF Binding Kit
KRAS G12C/cRAF binding assay: A novel tool for targeted drug screening and mechanism research
The RAS family genes are among the most frequently mutated oncogenes in human cancers, with KRAS mutations being particularly common and exhibiting high incidence in malignancies such as pancreatic cancer, colorectal cancer, and non-small cell lung cancer.
View details
- Cancer
- Human KRAS G12C & cRAF Binding Kit
- Pancreatic cancer
- Colorectal cancer
- 1












